+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens



Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated with Platinum-Based Regimens



Journal of the College of Physicians and Surgeons--Pakistan 28(4): 292-296



To determine the disease characteristics of testicular germ cell tumor, biochemical/radiological response to chemotherapy and common toxicity profile. Case series. Institute of Nuclear Medicine and Oncology (INMOL), Lahore, from January 2010 to December 2013. Fifty-one patients with histologically proven testicular germ cell tumor, who fulfilled the pre-defined eligibility criteria, were selected. Presenting symptoms and disease stage were studied. Patients were staged according to the AJCC 2010 staging criteria and prognosis was classified according to the IGCCCG Classification of Metastatic Germ Cell Cancer. Initial chemotherapy treatment was based upon the International Germ Cell Consensus Classification, 1997. Patients were also evaluated for chemotherapy-induced toxicity based on Common Toxicology Criteria version 4. SPSS version 16.0 was used for statistical analysis. Main presenting symptoms included testicular pain (37.3%), testicular swelling (25.5%), and abdominopelvic pain (11.8%). Most of the patients had mixed germ cell histology (p <0.001) and presented with advanced disease stage. Out of 51 patients, 41 (80.3%) achieved complete clinical remission after first line chemotherapy. All patients having complete response achieved 2-year survival and 37 (90.2%) had no evidence of recurrent disease. Four patients with recurrent disease achieved complete remission with second line chemotherapy. Five (9.8%) had partial response after first line chemotherapy while 2 (3.9%) progressed on treatment. All patients developed alopecia, 21 (41.1%) experienced other toxicities which were managed symptomatically and with minor dose modifications. Many patients with germ cell tumors presented with pain, and in an advanced stage, with mixed histology. Overall response rate was 90.2% with platinum-based chemotherapy.

(PDF emailed within 1 workday: $29.90)

Accession: 058427248

Download citation: RISBibTeXText

PMID: 29615170


Related references

Clinical characteristics, treatment and outcome of patients with bilateral testicular germ cell tumors. European Journal of Cancer 37(Supplement 6): S225, 2001

The antiemetic effect of methylprednisolone in patients treated with cis-platinum (CDDP) for advanced testicular germ cell tumors. Chemioterapia 3(4): 223-226, 1984

Fertility of patients with germ cell tumors of the testis before and after treatment with platinum and etoposide containing combination chemotherapy regimens. Jones, W G , A M Ward And C K Anderson (Ed ) Advances in The Biosciences, Vol 55 Germ Cell Tumours Ii; Conference, Leeds, England, Apr 15-19, 1985 Xv+505p Pergamon Press Ltd : Oxford, England; New York, N Y , Usa Illus 467-470, 1986

Characteristics and outcome of bilateral germ cell testicular tumors (BGCTT). 2007

Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer 109(3): 528-535, 2006

Treatment outcome on 52 patients with 53 testicular germ cell tumors. Hinyokika Kiyo. Acta Urologica Japonica 44(11): 789-794, 1999

Treatment of testicular intraepithelial neoplasia (intratubular germ cell neoplasia unspecified) with local radiotherapy or with platinum-based chemotherapy: a survey of the German Testicular Cancer Study Group. Annals of Oncology 24(5): 1332-1337, 2013

Treatment outcome and cost-effectiveness analysis of two chemotherapeutic regimens (BEP vs. VIP) for poor-prognosis metastatic germ cell tumors. Journal of Cancer Research and Therapeutics 3(3): 150-152, 2007

Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials. Cancer ChemoTherapy and Pharmacology 69(5): 1265-1275, 2012

Synchronous bilateral testicular germ cell tumors of different histologic type. Pathogenetic and practical implications of bilaterality in testicular germ cell tumors. Cancer 68(5): 1082-1085, 1991

Recent advances in management of patients with platinum-refractory testicular germ cell tumors. Cancer 106(6): 1217-1226, 2006

Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. Neoplasia 6(4): 297-301, 2004

The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary. Journal of Cancer Research and Clinical Oncology 129(5): 309-315, 2003

Malignant germ cell ovarian tumors: clinical characteristics, treatment and outcome. Cirugia Y Cirujanos 75(2): 81-85, 2007

Multimodality treatment of advanced malignant germ cell tumors in males 1. experience with cis platinum based combination chemotherapy. Scandinavian Journal of Urology and Nephrology 18(1): 13-20, 1984